Clinical Trial Update: A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China

View source ↗

Summary

A study to assess the real-world effectiveness of mavacamten in adult patients with obstructive hypertrophic cardiomyopathy in China is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hypertrophic Cardiomyopathy | Status: RECRUITING